• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《2022年欧洲神经肿瘤学会关于尿路尿路上皮肿瘤记录与报告的建议》

The 2022 ENCR Recommendations on recording and reporting of urothelial tumours of the urinary tract.

作者信息

Galceran Jaume, Parada David, Eden Michael, Tumino Rosario, Warren Anne Yvonne, Martos Carmen, Neamtiu Luciana, Visser Otto, Daubisse-Marliac Laetitia

机构信息

Cancer Epidemiology and Prevention Service, Hospital Universitari Sant Joan de Reus, Reus, Spain.

Institut d'Investigacions Sanitàries Pere Virgili (IISPV), Reus, Spain.

出版信息

Front Oncol. 2022 Nov 23;12:1046239. doi: 10.3389/fonc.2022.1046239. eCollection 2022.

DOI:10.3389/fonc.2022.1046239
PMID:36505871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9727225/
Abstract

An updated European Network of Cancer registries (ENCR) Recommendations on Recording and Reporting of Urothelial Tumours of the Urinary Tract had been published in 2022. After the publication by the ENCR of the "Recommendations for coding bladder cancers" in 1995, knowledge about the biology and pathology of urinary tract tumors and their classification has varied and increased substantially. On the other hand, several studies have shown that cancer registries use different definitions, criteria for inclusion and coding of urothelial tumors. This great variability among registries affects not only the criteria for recording (registration, coding and classification) but also the criteria of reporting (counting in the statistics of incidence and survival) urinary tract tumors. This causes difficulties in the data comparability from different registries. Recording and reporting of urothelial tumors requires the application of standard criteria that must take into account the combination of the multiple aspects as the primary topography, the histological type, the grade, the extent of invasion, the multi-centricity, the progressions and the time interval between tumors. This led to the creation of a Working Group of the ENCR that developed these recommendations on the recording and reporting of urothelial tumors of the urinary tract. This article reports these recommendations and the rationale for each.

摘要

欧洲癌症登记处网络(ENCR)发布了关于尿路尿路上皮肿瘤记录与报告的最新建议,该建议于2022年发布。自1995年ENCR发布“膀胱癌编码建议”以来,关于尿路肿瘤的生物学、病理学及其分类的知识有了很大变化且大幅增加。另一方面,多项研究表明,癌症登记处对尿路上皮肿瘤的定义、纳入标准和编码方式各不相同。登记处之间的这种巨大差异不仅影响记录标准(登记、编码和分类),还影响尿路肿瘤的报告标准(发病率和生存率统计中的计数)。这给不同登记处的数据可比性带来了困难。尿路上皮肿瘤的记录和报告需要应用标准标准,这些标准必须考虑到多个方面的组合,如主要部位、组织学类型、分级、浸润范围、多中心性、进展情况以及肿瘤之间的时间间隔。这促使ENCR成立了一个工作组,制定了这些关于尿路尿路上皮肿瘤记录与报告的建议。本文报告了这些建议及其各自的理由。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1836/9727225/ca7404e62836/fonc-12-1046239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1836/9727225/ca7404e62836/fonc-12-1046239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1836/9727225/ca7404e62836/fonc-12-1046239-g001.jpg

相似文献

1
The 2022 ENCR Recommendations on recording and reporting of urothelial tumours of the urinary tract.《2022年欧洲神经肿瘤学会关于尿路尿路上皮肿瘤记录与报告的建议》
Front Oncol. 2022 Nov 23;12:1046239. doi: 10.3389/fonc.2022.1046239. eCollection 2022.
2
Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?癌症登记处中尿路上皮肿瘤的登记:如何改进使其更有用?
Int J Environ Res Public Health. 2022 Feb 25;19(5):2714. doi: 10.3390/ijerph19052714.
3
Are epidemiological data on lymphoma incidence comparable? Results from an application of the coding recommendations of WHO, InterLymph, ENCR and SEER to a cancer registry dataset.淋巴瘤发病率的流行病学数据具有可比性吗?将世界卫生组织、国际淋巴瘤研究组、欧洲癌症登记处和美国监测、流行病学和最终结果项目的编码建议应用于癌症登记数据集的结果。
J Cancer Res Clin Oncol. 2016 Jan;142(1):167-75. doi: 10.1007/s00432-015-2017-z. Epub 2015 Jul 24.
4
Coding criteria of bladder cancer: effects on estimating survival.膀胱癌的编码标准:对生存估计的影响。
Epidemiol Prev. 2001;25(3 Suppl):42-7.
5
Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnoses.迈向血液系统恶性肿瘤的最佳临床和流行病学登记:记录进展、转化和多重诊断的指南
Eur J Cancer. 2015 Jun;51(9):1109-22. doi: 10.1016/j.ejca.2014.02.008. Epub 2014 Mar 12.
6
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.欧洲泌尿外科学会上尿路上皮细胞癌指南:2015 年更新版。
Eur Urol. 2015 Nov;68(5):868-79. doi: 10.1016/j.eururo.2015.06.044. Epub 2015 Jul 16.
7
The Joint Research Centre-European Network of Cancer Registries Quality Check Software (JRC-ENCR QCS).联合研究中心-欧洲癌症登记处网络质量检查软件(JRC-ENCR QCS)
Front Oncol. 2023 Oct 26;13:1250195. doi: 10.3389/fonc.2023.1250195. eCollection 2023.
8
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2017 年更新版。
Eur Urol. 2018 Jan;73(1):111-122. doi: 10.1016/j.eururo.2017.07.036. Epub 2017 Sep 1.
9
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.国际泌尿病理学会(ISUP)膀胱癌共识会议:当前问题。工作小组 2:混合分级、浸润性尿路上皮癌(包括组织学亚型和不同分化)和非尿路上皮癌的分级。
Am J Surg Pathol. 2024 Jan 1;48(1):e11-e23. doi: 10.1097/PAS.0000000000002077. Epub 2023 Jun 29.
10
Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies.共聚焦激光内镜检查在膀胱和上尿路尿路上皮癌诊断中的应用:两项前瞻性探索性研究方案
JMIR Res Protoc. 2018 Feb 7;7(2):e34. doi: 10.2196/resprot.8862.

引用本文的文献

1
A diagnostic model for non-invasive urothelial cancer early detection based on methylation of urinary tumor DNA.基于尿肿瘤DNA甲基化的非侵入性尿路上皮癌早期检测诊断模型。
Cancer Cell Int. 2025 Apr 15;25(1):148. doi: 10.1186/s12935-025-03766-2.
2
Facing further challenges in cancer data quality and harmonisation.癌症数据质量与整合面临进一步挑战。
Front Oncol. 2024 Jul 25;14:1438805. doi: 10.3389/fonc.2024.1438805. eCollection 2024.
3
The Joint Research Centre-European Network of Cancer Registries Quality Check Software (JRC-ENCR QCS).

本文引用的文献

1
Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?癌症登记处中尿路上皮肿瘤的登记:如何改进使其更有用?
Int J Environ Res Public Health. 2022 Feb 25;19(5):2714. doi: 10.3390/ijerph19052714.
2
Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies.膀胱癌更新的病理学报告标准:活检、经尿道切除术和根治性膀胱切除术。
World J Urol. 2022 Apr;40(4):915-927. doi: 10.1007/s00345-021-03831-1. Epub 2021 Sep 23.
3
Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR).
联合研究中心-欧洲癌症登记处网络质量检查软件(JRC-ENCR QCS)
Front Oncol. 2023 Oct 26;13:1250195. doi: 10.3389/fonc.2023.1250195. eCollection 2023.
国际癌症报告协作组织(ICCR)关于泌尿道上皮癌活检和经尿道切除标本报告的数据集建议。
Mod Pathol. 2020 Apr;33(4):700-712. doi: 10.1038/s41379-019-0403-9. Epub 2019 Nov 4.
4
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review.膀胱癌的尿路上皮和非尿路上皮组织学变异对肌层浸润性和转移性膀胱癌患者的肿瘤学结局的预测价值及临床重要性如何?欧洲泌尿外科学会肌层浸润性和转移性膀胱癌指南小组系统评价。
Eur Urol Oncol. 2019 Nov;2(6):625-642. doi: 10.1016/j.euo.2019.09.003. Epub 2019 Oct 8.
5
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.肌肉浸润性膀胱癌的共识分子分类。
Eur Urol. 2020 Apr;77(4):420-433. doi: 10.1016/j.eururo.2019.09.006. Epub 2019 Sep 26.
6
Reply re: Murali Varma, Brett Delahunt, Theodorus van der Kwast. Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question. Eur Urol 2019;76:413-5: Two Decades of World Health Organisation/International Society of Urological Pathology Bladder Cancer Grading: Time to Reflect on Accomplishments and Plan Refinement in the Molecular Era, Not Regress to Readoption of a 45-year-old Classification.回复关于:穆拉利·瓦尔马、布雷特·德拉亨特、西奥多勒斯·范德·夸斯特。非侵袭性膀胱癌分级:采用世界卫生组织1973年或2004年标准可能是个错误的问题。《欧洲泌尿外科杂志》2019年;76卷:413 - 415页:世界卫生组织/国际泌尿病理学会膀胱癌分级二十年:是时候反思在分子时代的成就并规划改进了,而不是倒退到重新采用一个45年历史的分类标准。
Eur Urol. 2019 Oct;76(4):416-417. doi: 10.1016/j.eururo.2019.07.017. Epub 2019 Jul 24.
7
Bladder Cancer in the Genomic Era.膀胱癌的基因组时代
Arch Pathol Lab Med. 2019 Jun;143(6):695-704. doi: 10.5858/arpa.2018-0329-RA. Epub 2019 Jan 23.
8
Non-urothelial carcinomas of the bladder.膀胱非尿路上皮癌。
Histopathology. 2019 Jan;74(1):97-111. doi: 10.1111/his.13719.
9
Precursor lesions of the urinary bladder.膀胱的前驱病变。
Histopathology. 2019 Jan;74(1):68-76. doi: 10.1111/his.13762.
10
Staging of bladder cancer.膀胱癌分期。
Histopathology. 2019 Jan;74(1):112-134. doi: 10.1111/his.13734.